DoD Melanoma, Focused Program Award – Rare Melanomas
ID: 358950Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the DoD Melanoma, Focused Program Award aimed at advancing research on rare melanomas. This grant supports multidisciplinary teams to propose two to three complementary research projects centered around a common overarching question related to rare melanomas, with an emphasis on collaboration among Principal Investigators (PIs) from various institutions. The total funding available is $6.4 million, with approximately two awards expected, each providing up to $2 million over a maximum four-year period. Interested applicants must submit a pre-application by June 30, 2025, and, if invited, a full application by October 1, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Defense (DOD) is offering a funding opportunity through the Melanoma Research Program (MRP) for multidisciplinary research addressing rare melanomas. This Focused Program Award allows teams of researchers to propose 2-3 complementary projects centered on an overarching question relevant to rare melanomas. Eligible applicants include both extramural and intramural organizations, with specific eligibility requirements for Principal Investigators (PIs). The program aims to advance understanding, prevention, and treatment of rare melanomas, with an emphasis on engaging the rare melanoma consumer community for enhanced research impact. The funding is capped at $6.4 million for approximately two applications, offering up to $2 million each over a maximum four-year period. Interested researchers must submit a pre-application by June 30, 2025, and if invited, a full application by October 1, 2025. Successful candidates will be notified by late 2025, with funding starting no later than September 30, 2026. The document outlines detailed submission and review processes, application components, and the importance of collaboration among PIs from various institutions. Overall, the initiative underscores DOD's commitment to improving healthcare outcomes for Service Members, Veterans, and their families impacted by rare melanomas.
    Similar Opportunities
    Loading similar opportunities...